These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 29619895)
21. Performance evaluation of HbA1c measurement systems with sigma metric for 1066 laboratories in China. Huang Y; Zhang T; Zhao H; Wang W; Zhang C; He F; Zhong K; Yuan S; Du Y; Wang Z Clin Chim Acta; 2018 Dec; 487():281-286. PubMed ID: 30312599 [TBL] [Abstract][Full Text] [Related]
22. Diabetes risk assessments and HbA1c-measurements in community pharmacies. Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ Int J Pharm Pract; 2023 Sep; 31(5):512-519. PubMed ID: 37527496 [TBL] [Abstract][Full Text] [Related]
23. Diabetes care in Norwegian pharmacies: a descriptive study. Kjome RL; Sandberg S; Granås AG Pharm World Sci; 2008 Apr; 30(2):191-8. PubMed ID: 17891470 [TBL] [Abstract][Full Text] [Related]
24. Hemoglobin A1c: assessment of three POC analyzers relative to a central laboratory method. Petersen JR; Omoruyi FO; Mohammad AA; Shea TJ; Okorodudu AO; Ju H Clin Chim Acta; 2010 Dec; 411(23-24):2062-6. PubMed ID: 20832393 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of Four HbA1c Point-of-Care Devices Using International Quality Targets: Are They Fit for the Purpose? Lenters-Westra E; English E J Diabetes Sci Technol; 2018 Jul; 12(4):762-770. PubMed ID: 29921132 [TBL] [Abstract][Full Text] [Related]
26. Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy. Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Mc Namara KP Diabetes Res Clin Pract; 2023 Mar; 197():110566. PubMed ID: 36738834 [TBL] [Abstract][Full Text] [Related]
27. Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany. Heinemann L; Kaiser P; Freckmann G; Grote-Koska D; Kerner W; Landgraf R; Merker L; Müller UA; Müller-Wieland D; Roth J; Spannagl M; Wallaschofski H; Nauck M Horm Metab Res; 2018 Oct; 50(10):728-734. PubMed ID: 30216941 [TBL] [Abstract][Full Text] [Related]
28. Point-of-care urine albumin in general practice offices: effect of participation in an external quality assurance scheme. Bukve T; Røraas T; Riksheim BO; Christensen NG; Sandberg S Clin Chem Lab Med; 2015 Jan; 53(1):45-51. PubMed ID: 25153401 [TBL] [Abstract][Full Text] [Related]
29. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy. Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931 [TBL] [Abstract][Full Text] [Related]
30. Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial. Krass I; Twigg MJ; Mitchell B; Wilson F; Mohebbi M; Trinder P; Shih STF; Carter R; Versace VL; McNamara K BMC Health Serv Res; 2023 Dec; 23(1):1337. PubMed ID: 38041094 [TBL] [Abstract][Full Text] [Related]
31. Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy. Santana CR; de Oliveira MGG; Camargo MS; Moreira PMB; de Castro PR; Aguiar EC; Mistro S Int J Pharm Pract; 2024 Feb; 32(1):46-51. PubMed ID: 37936510 [TBL] [Abstract][Full Text] [Related]
32. HbA1c: a review of analytical and clinical aspects. Weykamp C Ann Lab Med; 2013 Nov; 33(6):393-400. PubMed ID: 24205486 [TBL] [Abstract][Full Text] [Related]
33. Impact of HbA1c Testing at Point of Care on Diabetes Management. Schnell O; Crocker JB; Weng J J Diabetes Sci Technol; 2017 May; 11(3):611-617. PubMed ID: 27898388 [TBL] [Abstract][Full Text] [Related]
34. Fingerstick Precision and Total Error of a Point-of-Care HbA1c Test. Arnold WD; Kupfer K; Hvidsten Swensen M; Fortner KS; Bays HE; Davis M; Klaff LJ; San George RC J Diabetes Sci Technol; 2020 Sep; 14(5):890-895. PubMed ID: 30841743 [TBL] [Abstract][Full Text] [Related]
35. Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study. Barron E; Misra S; English E; John WG; Sampson M; Bachmann MO; Barth J; Oliver N; Alberti KGMM; Bakhai C; O'Neill S; Young B; Wareham NJ; Khunti K; Jebb S; Smith J; Valabhji J BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33318069 [TBL] [Abstract][Full Text] [Related]
37. An update on quality control for the PFA-100/PFA-200. Favaloro EJ; Bonar R Platelets; 2018 Sep; 29(6):622-627. PubMed ID: 29792545 [TBL] [Abstract][Full Text] [Related]
38. Point-of-Care Hemoglobin A1c Testing: An Evidence-Based Analysis. Health Quality Ontario Ont Health Technol Assess Ser; 2014; 14(8):1-30. PubMed ID: 26316922 [TBL] [Abstract][Full Text] [Related]
39. Accuracy and Precision of a Point-of-Care HbA1c Test. Arnold WD; Kupfer K; Little RR; Amar M; Horowitz B; Godbole N; Hvidsten Swensen M; Li Y; San George RC J Diabetes Sci Technol; 2020 Sep; 14(5):883-889. PubMed ID: 30854894 [TBL] [Abstract][Full Text] [Related]
40. Implementation of a method for glucose measurements in community pharmacies. Kjome RL; Nerhus K; Sandberg S Int J Pharm Pract; 2010 Feb; 18(1):13-9. PubMed ID: 20405591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]